Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 6/2016

Open Access 01-06-2016 | Original Article

Screening for psychological distress in follow-up care to identify head and neck cancer patients with untreated distress

Authors: Anne-Marie H. Krebber, Femke Jansen, Pim Cuijpers, C. René Leemans, Irma M. Verdonck-de Leeuw

Published in: Supportive Care in Cancer | Issue 6/2016

Login to get access

Abstract

Purpose

The purpose of the study is to investigate screening in follow-up care to identify head and neck cancer (HNC) patients with untreated psychological distress.

Methods

From November 2009 until December 2012, we investigated the use of OncoQuest (a touch screen computer system to monitor psychological distress (Hospital Anxiety and Depression Scale (HADS)) and quality of life (HRQOL; EORTC QLQ-C30 and H&N35 module) in routine follow-up care. Patients who screened positive for psychological distress (HADS-T >14, HADS-A >7, or HADS-D >7) were asked whether they received psychological or psychiatric treatment.

Results

During the study period of 37 months, OncoQuest was used by 720 individual HNC patients, of whom 714 had complete HADS data. Psychological distress was present in 206 patients (29 %). Of those patients who fulfilled in- and exclusion criteria (n = 137), 25 received psychological treatment (18 %). Receipt of psychological treatment was significantly related to a higher score on the HADS total scale (19.6 vs. 16.9; p = 0.019), a lower (worse) score on the EORTC QLQ-C30 scale emotional functioning (46.0 vs. 58.6; p = 0.023), a higher (worse) score on fatigue (58.2 vs. 46.4; p = 0.032), problems with sexuality (44.1 vs. 34.4; p = 0.043), oral pain (43.8 vs. 28.8; p = 0.011) and speech problems (37.0 vs. 25.3; p = 0.042).

Conclusions

Screening for psychological distress via OncoQuest is beneficial because 82 % of HNC patients identified with an increased level of distress who do not yet receive mental treatment were identified. Patients who did receive treatment reported more distress and worse quality of life, which may be explained because patients with more severe problems maybe more inclined to seek help or might be detected easier by caregivers and referred to supportive care more often.
Literature
1.
2.
3.
4.
Hart SL, Hoyt MA, Diefenbach M, Anderson DR, Kilbourn KM, Craft LL, Steel JL, Cuijpers P, Mohr DC, Berendsen M, Spring B, Stanton AL (2012) Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst 104:990–1004. doi:10.​1093/​jnci/​djs256 CrossRefPubMedPubMedCentral
5.
Faller H, Schuler M, Richard M, Heckl U, Weis J, Kuffner R (2013) Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol 31:782–793. doi:10.​1200/​JCO.​2011.​40.​8922 CrossRefPubMed
6.
Galway K, Black A, Cantwell M, Cardwell CR, Mills M, Donnelly M (2012) Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients. Cochrane Database Syst Rev 11:CD007064. doi:10.​1002/​14651858.​CD007064.​pub2 PubMed
7.
Verdonck-de Leeuw IM, de Bree R, Keizer AL, Houffelaar T, Cuijpers P, van der Linden MH, Leemans CR (2009) Computerized prospective screening for high levels of emotional distress in head and neck cancer patients and referral rate to psychosocial care. Oral Oncol 45:e129–133. doi:10.​1016/​j.​oraloncology.​2009.​01.​012 CrossRefPubMed
8.
Waller A, Williams A, Groff SL, Bultz BD, Carlson LE (2013) Screening for distress, the sixth vital sign: examining self-referral in people with cancer over a one-year period. Psychooncology 22(2):388–395. doi:10.​1002/​pon.​2102 PubMed
9.
Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, MacRae JH, Martin M, Pelletier G, Robinson J, Simpson JS, Speca M, Tillotson L, Bultz BD (2004) High levels of untreated distress and fatigue in cancer patients. Br J Cancer 90:2297–2304. doi:10.​1038/​sj.​bjc.​6601887 PubMedPubMedCentral
10.
11.
12.
13.
Donovan KA, Jacobsen PB (2013) Progress in the implementation of NCCN guidelines for distress management by member institutions. J Natl Compr Canc Netw 11:223–226PubMed
14.
Mitchell AJ, Kaar S, Coggan C, Herdman J (2008) Acceptability of common screening methods used to detect distress and related mood disorders-preferences of cancer specialists and non-specialists. Psychooncology 17:226–236. doi:10.​1002/​pon.​1228 CrossRefPubMed
15.
16.
17.
Mitchell AJ (2010) Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. J Natl Compr Canc Netw 8:487–494PubMed
18.
19.
Loscalzo M, Clark K, Dillehunt J, Rinehart R, Strowbridge R, Smith D (2010) SupportScreen: a model for improving patient outcomes. J Natl Compr Canc Netw 8:496–50
20.
21.
Holzner B, Giesinger JM, Pinggera J, Zugal S, Schopf F, Oberguggenberger AS, Gamper EM, Zabernigg A, Weber B, Rumpold G (2012) The Computer-based Health Evaluation Software (CHES): a software for electronic patient-reported outcome monitoring. BMC Med Inform Decis Mak 12:126. doi:10.​1186/​1472-6947-12-126 CrossRefPubMedPubMedCentral
22.
Cnossen IC, de Bree R, Rinkel RN, Eerenstein SE, Rietveld DH, Doornaert P, Buter J, Langendijk JA, Leemans CR, Verdonck-de Leeuw IM (2012) Computerized monitoring of patient-reported speech and swallowing problems in head and neck cancer patients in clinical practice. Support Care Cancer 20:2925–2931. doi:10.​1007/​s00520-012-1422-y CrossRefPubMedPubMedCentral
23.
24.
25.
Carlson LE, Waller A, Groff SL, Bultz BD (2013) Reply: comment on ‘Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomised controlled trial of computerised vs personalised triage’—psychological distress in patients with cancer: is screening the effective solution? Br J Cancer 108:2631–2632. doi:10.​1038/​bjc.​2013.​287 CrossRefPubMedPubMedCentral
26.
Carlson LE, Waller A, Groff SL, Bultz BD (2013) Screening for distress, the sixth vital sign, in lung cancer patients: effects on pain, fatigue, and common problems—secondary outcomes of a randomized controlled trial. Psychooncology 22:1880–1888. doi:10.​1002/​pon.​3223 CrossRefPubMed
27.
28.
29.
30.
31.
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed
32.
Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM (1997) A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27:363–370CrossRefPubMed
33.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed
34.
Bjordal K, Ahlner-Elmqvist M, Tollesson E, Jensen AB, Razavi D, Maher EJ, Kaasa S (1994) Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 33:879–885CrossRefPubMed
35.
Fayers P, Bottomley A, Group EQoL, Unit QoL (2002) Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 38(Suppl 4):S125–133CrossRefPubMed
36.
37.
38.
Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, MacGillivray S (2014) What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol 32:1480–1501. doi:10.​1200/​jco.​2013.​53.​5948 CrossRefPubMed
39.
Luckett T, Butow PN, King MT (2009) Improving patient outcomes through the routine use of patient-reported data in cancer clinics: future directions. Psychooncology 18:1129–1138. doi:10.​1002/​pon.​1545 CrossRefPubMed
40.
Jansen F, van Uden-Kraan CF, van Zwieten V, Witte BI, Verdonck-de Leeuw IM (2015) Cancer survivors’ perceived need for supportive care and their attitude towards self-management and eHealth. Support Care Cancer 23:1679–88. doi:10.​1007/​s00520-014-2514-7 CrossRefPubMed
41.
Lubberding S, van Uden-Kraan CF, Te Velde EA, Cuijpers P, Leemans CR, Verdonck-de Leeuw IM (2015) Improving access to supportive cancer care through an eHealth application: a qualitative needs assessment among cancer survivors. J Clin Nurs 24:1367–79. doi:10.​1111/​jocn.​12753 CrossRefPubMed
42.
Krebber AM, Leemans CR, de Bree R, van Straten A, Smit F, Smit EF, Becker A, Eeckhout GM, Beekman AT, Cuijpers P, Verdonck-de Leeuw IM (2012) Stepped care targeting psychological distress in head and neck and lung cancer patients: a randomized clinical trial. BMC cancer 12:173. doi:10.​1186/​1471-2407-12-173 CrossRefPubMedPubMedCentral
43.
Metadata
Title
Screening for psychological distress in follow-up care to identify head and neck cancer patients with untreated distress
Authors
Anne-Marie H. Krebber
Femke Jansen
Pim Cuijpers
C. René Leemans
Irma M. Verdonck-de Leeuw
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 6/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-3053-6

Other articles of this Issue 6/2016

Supportive Care in Cancer 6/2016 Go to the issue

Original Article

Psychometric properties of the Arabic version of EORTC QLQ-C15-PAL among cancer patients in Jordan

Original Article

How calls from carers, friends and family members of someone affected by cancer differ from those made by people diagnosed with cancer; analysis of 4 years of South Australian Cancer Council Helpline data

Review Article

Permanent catheters for recurrent ascites—a critical and systematic review of study methodology

Original Article

Aromatase inhibitor associated arthralgia: the importance of oncology provider-patient communication about side effects and potential management through physical activity

Original Article

Topical application of Aloe vera and vitamin E on induced ulcers on the tongue of rats subjected to radiation: clinical and histological evaluation

Original Article

Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits